Yabao Pharmaceutical Group Co., Ltd. set of drug development, production and logistics in one, is the first stock listed on the pharmaceutical industry in Shanxi Province company and the first high-tech enterprises, and ranked among the top 50 proprietary Chinese medicine. "Ah Bao" trademark well-known trademarks in China. Company consists of five branches, 13 subsidiaries and employs more than 6,000 people. Total assets of 2.4 billion, annual sales income of 1.5 billion, annual profits of $ 300 million, and ranked among the top 50 proprietary companies.

company's products are mainly in Western medicine, bulk drugs and pharmaceutical packaging materials, a total of more than 300 varieties. Cerebrovascular disease and heart medication drugs in women and children formed a strong brand, which patented products paste umbilical Dinggui children are exclusive production for the iconic brand in Shanxi Province, well-known at home and abroad, exported to Southeast Asian countries; ZJ , Troxerutin tablets, nimodipine tablets, compound reserpine tablets such sales are the first in the country.

company research strength, the establishment of a state-level enterprise technology center, Beijing Institute of Pharmaceutical Research, Drug Research Center Taiyuan research and development institutions, forming a three-dimensional R & D system, a master's and doctoral degrees or higher professional R & D staff of nearly 100 people in Beijing to establish a post-doctoral research station, with modern medicine, biological medicine and new chemical drug delivery systems for the Major R & D direction. The company has made 29 invention patent, utility patent number 70, is currently developing 80 projects, mainly for advanced slow release agents, biological agents, the countries targeted drug delivery nano first and second drug .
Company's eight production bases in operation, all passed the GMP certification, according to GMP requires the establishment of a strict quality supervision and control system, were equipped with international advanced quality testing equipment, and build each product higher than the national statutory standards of quality control standard, to ensure drug quality. The new Beijing Industrial Park, biopharmaceutical and Fenglingdu production line controlled release formulations, with a total investment of 500 million yuan, in full accordance with U.S. FDA and EU cGMP standards development, its products will be exported to European and American high-end market with annual exports will reach nearly 2 billion.

different types of drugs the company according to sales channels and a different focus, namely the establishment of specialized commercial distribution, drug agency , OTC sales, academic promotion and international trade team, with all kinds of marketing staff more than 3,000 people, sales network covering 30 provinces and cities high low-end market, now being built in Shanxi Province's largest pharmaceutical distribution centers.

companies have been awarded the National Labor Award, the national quality and efficiency of advanced enterprises, the National Trustworthy business, China most promising companies, the top ten corporate culture, brand, national poverty alleviation leading enterprises Honor.

company to "do hard drugs, the benefit of mankind" as a concept, and constantly doing fine products and excellent service, do Strong companies, big brands, to build "the world Asia treasure, treasure century Asia", determined the cause of human health and make greater contributions to